Search Results - "Ryabicheva, Tatiana G."

Analysis of the Biological Properties of Blood Plasma Protein with GcMAF Functional Activity by Dolgova, Evgeniya V, Kirikovich, Svetlana S, Levites, Evgeniy V, Ruzanova, Vera S, Proskurina, Anastasia S, Ritter, Genrikh S, Taranov, Oleg S, Varaksin, Nikolay A, Ryabicheva, Tatiana G, Leplina, Olga Yu, Ostanin, Alexandr A, Chernykh, Elena R, Bogachev, Sergey S

“…The main problem related to the studies focusing on group-specific component protein-derived macrophage-activating factor (GcMAF) is the lack of clarity about…”
Get full text

Effects of Recombinant Angiogenin on Collagen Fiber Formation and Angiogenesis in the Dermis of Wistar Rats by Yurina, Natalia V, Ageeva, Tatiana A, Goryachkin, Aleksandr M, Varaksin, Nikolay A, Ryabicheva, Tatiana G, Ostanin, Alexandr A, Chernykh, Elena R, Romashchenko, Alexander V, Proskurina, Anastasia S, Bogachev, Sergey, Purtov, Alexey V

“…The purpose of this study was to assess the capability of recombinant angiogenin isolated from yeasts to stimulate regenerative processes in the dermis of…”
Get full text

Features of monocyte-derived dendritic cells encompassing a rare subpopulation of cells that are capable of natural internalization of extracellular dsDNA by Proskurina, Anastasia S, Spaselnikova, Alisa V, Ritter, Genrikh S, Dolgova, Evgenia V, Potter, Ekaterina A, Romanenko, Margarita V, Netesov, Sergey V, Efremov, Yaroslav R, Taranov, Oleg S, Varaksin, Nikolay A, Ryabicheva, Tatiana G, Ostanin, Aleksandr A, Chernykh, Elena R, Bogachev, Sergey S

“…The present study demonstrates that monocyte-derived dendritic cells (moDCs) produced in vitro using a GM-CSF and IFN-α differentiation protocol encompass a…”
Get full text

Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen by Proskurina, Anastasia S, Gvozdeva, Tatiana S, Potter, Ekaterina A, Dolgova, Evgenia V, Orishchenko, Konstantin E, Nikolin, Valeriy P, Popova, Nelly A, Sidorov, Sergey V, Chernykh, Elena R, Ostanin, Alexandr A, Leplina, Olga Y, Dvornichenko, Victoria V, Ponomarenko, Dmitriy M, Soldatova, Galina S, Varaksin, Nikolay A, Ryabicheva, Tatiana G, Uchakin, Peter N, Rogachev, Vladimir A, Shurdov, Mikhail A, Bogachev, Sergey S

“…We report on the results of a phase II clinical trial of Panagen (tablet form of fragmented human DNA preparation) in breast cancer patients (placebo group n =…”
Get full text

Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer by Proskurina, Anastasia S, Gvozdeva, Tatiana S, Alyamkina, Ekaterina A, Dolgova, Evgenia V, Orishchenko, Konstantin E, Nikolin, Valeriy P, Popova, Nelly A, Sidorov, Sergey V, Chernykh, Elena R, Ostanin, Alexandr A, Leplina, Olga Y, Dvornichenko, Victoria V, Ponomarenko, Dmitriy M, Soldatova, Galina S, Varaksin, Nikolay A, Ryabicheva, Tatiana G, Uchakin, Peter N, Zagrebelniy, Stanislav N, Rogachev, Vladimir A, Bogachev, Sergey S, Shurdov, Mikhail A

“…We performed a multicenter, double-blind, placebo-controlled, phase II clinical trial of human dsDNA-based preparation Panagen in a tablet form. In total, 80…”
Get full text

Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer by Proskurina, Anastasia S, Gvozdeva, Tatiana S, Alyamkina, Ekaterina A, Dolgova, Evgenia V, Orishchenko, Konstantin E, Nikolin, Valeriy P, Popova, Nelly A, Sidorov, Sergey V, Chernykh, Elena R, Ostanin, Alexandr A, Leplina, Olga Y, Dvornichenko, Victoria V, Ponomarenko, Dmitriy M, Soldatova, Galina S, Varaksin, Nikolay A, Ryabicheva, Tatiana G, Uchakin, Peter N, Zagrebelniy, Stanislav N, Rogachev, Vladimir A, Bogachev, Sergey S, Shurdov, Mikhail A

Get full text

Effects of human exogenous DNA on production of perforin-containing CD8+ cytotoxic lymphocytes in laboratory setting and clinical practice by Alyamkina, Ekaterina A., Leplina, Olga Y., Ostanin, Alexandr A., Chernykh, Elena R., Nikolin, Valeriy P., Popova, Nelly A., Proskurina, Anastasia S., Gvozdeva, Tatiana S., Dolgova, Evgenia V., Orishchenko, Konstantin E., Rogachev, Vladimir A., Sidorov, Sergey V., Varaksin, Nikolay A., Ryabicheva, Tatiana G., Bogachev, Sergey S., Shurdov, Mikhail A.

“…► Polycytostatic treatment results in suppression of tumor growth in mice. ► Human DNA preparation significantly enhances anticancer effects of cytostatic…”
Get full text